Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Hoffmann

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cells|April 3, 2021
Genetic Deletion of Polo-Like Kinase 2 Induces a Pro-Fibrotic Pulmonary PhenotypeTheresa A Kant, Manja Newe, Luise Winter, et al.
Clinical Immunology (Orlando, Fla.)|January 22, 2022
Interleukin-7 and soluble Interleukin-7 receptor levels in type 1 diabetes - Impact of IL7RA polymorphisms, HLA risk genotypes and clinical featuresMaximilian Hoffmann, Jürgen Enczmann, Vera Balz, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 16, 2020
Repurposing mesalazine against cardiac fibrosis in vitroMaximilian Hoffmann, Theresa A Kant, Ramona Emig, et al.
FEBS Open Bio|May 19, 2020
Modeling atrial fibrosis in vitro-Generation and characterization of a novel human atrial fibroblast cell lineStephan R Künzel, Johanna S E Rausch, Charlotte Schäffer, et al.
Scientific Reports|October 31, 2024
Radiation-induced morphea of the breast - characterization and treatment of fibroblast dysfunction with repurposed mesalazineStephan R Künzel, Erik Klapproth, Nick Zimmermann, et al.
Circulation Research|August 26, 2021
Diminished PLK2 Induces Cardiac Fibrosis and Promotes Atrial FibrillationStephan R Künzel, Maximilian Hoffmann, Silvio Weber, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cells|April 3, 2021
Genetic Deletion of Polo-Like Kinase 2 Induces a Pro-Fibrotic Pulmonary PhenotypeTheresa A Kant, Manja Newe, Luise Winter, et al.
Clinical Immunology (Orlando, Fla.)|January 22, 2022
Interleukin-7 and soluble Interleukin-7 receptor levels in type 1 diabetes - Impact of IL7RA polymorphisms, HLA risk genotypes and clinical featuresMaximilian Hoffmann, Jürgen Enczmann, Vera Balz, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 16, 2020
Repurposing mesalazine against cardiac fibrosis in vitroMaximilian Hoffmann, Theresa A Kant, Ramona Emig, et al.
FEBS Open Bio|May 19, 2020
Modeling atrial fibrosis in vitro-Generation and characterization of a novel human atrial fibroblast cell lineStephan R Künzel, Johanna S E Rausch, Charlotte Schäffer, et al.
Scientific Reports|October 31, 2024
Radiation-induced morphea of the breast - characterization and treatment of fibroblast dysfunction with repurposed mesalazineStephan R Künzel, Erik Klapproth, Nick Zimmermann, et al.
Circulation Research|August 26, 2021
Diminished PLK2 Induces Cardiac Fibrosis and Promotes Atrial FibrillationStephan R Künzel, Maximilian Hoffmann, Silvio Weber, et al.
Pageof 3